JENNIFER EDGAR: Open Payments
NPI 1013107366 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 17 payments from 7 companies in 2025. Trend: 2023 $247 · 2024 $190 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 7 | $171 |
| ARGENX US, INC. | 3 | $81 |
| UCB, Inc. | 3 | $50 |
| Janssen Biotech, Inc. | 1 | $34 |
| SK Life Science, Inc. | 1 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
Products named: TYSABRI, VYVGART HYTRULO, Rystiggo, SKYCLARYS, KEVEYIS, NUPLAZID, Kygevvi.
Industry payments across KY — which companies pay providers there.
